Experiment 1177052

Worktypes

REVIEW OFANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

ALANOSINE

Alerts

THESE DATA ARE FROM A REVIEW ARTICLE.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIV
OrganismEmpty organism
CitationMARSONI,S: HOTH,D: SIMON,R: LEYLAND-JONES,B: DE ROSA,M: WITTES,RE:. (1987). CLINICAL DRUG DEVELOPMENT: AN ANALYSIS OF PHASE II TRIALS, 1970-1985.. 71(1)
Amount utilized
Compound isolated
DiseaseANALYSIS OF PHASE II TRIALS FROM 1970-1985.
Dose amountVAR
Number1
Qualitative resultEQUIVOCAL
AnimalHUMAN ADULT
Dose expressionDOSE